Home
About
Overview
Sharing Data
ORCID
Help
History (26)
Plerixafor+G-CSF-mobilized CD34+ cells represent an optimal graft source for thalassemia gene therapy.
Discrepancy between post-treatment infarct volume and 90-day outcome in the ESCAPE randomized controlled trial.
Impact of alcohols on the formation and stability of protein-stabilized nanoemulsions.
Fertilization in Vitro
World Health Assembly Resolution 60.22. [corrected].
See All 26 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top